Katie R Mollan
Title
Cited by
Cited by
Year
Abacavir–lamivudine versus tenofovir–emtricitabine for initial HIV-1 therapy
PE Sax, C Tierney, AC Collier, MA Fischl, K Mollan, L Peeples, C Godfrey, ...
New England Journal of Medicine 361 (23), 2230-2240, 2009
3802009
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1
P Flandre
Annals of internal medicine 155 (6), 402, 2011
3512011
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data
KR Mollan, M Smurzynski, JJ Eron, ES Daar, TB Campbell, PE Sax, ...
Annals of internal medicine 161 (1), 1-10, 2014
1952014
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results
PE Sax, C Tierney, AC Collier, ES Daar, K Mollan, C Budhathoki, ...
Journal of Infectious Diseases 204 (8), 1191-1201, 2011
1952011
Crowdsourcing HIV test promotion videos: a noninferiority randomized controlled trial in China
W Tang, L Han, J Best, Y Zhang, K Mollan, J Kim, F Liu, M Hudgens, ...
Clinical infectious diseases 62 (11), 1436-1442, 2016
872016
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
TJ Wilkin, JE McKinnon, AG DiRienzo, K Mollan, CV Fletcher, ...
The Journal of infectious diseases 199 (6), 866-871, 2009
682009
Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial
W Tang, C Wei, B Cao, D Wu, KT Li, H Lu, W Ma, D Kang, H Li, M Liao, ...
PLoS medicine 15 (8), e1002645, 2018
532018
The differential short-and long-term effects of HIV-1 latency-reversing agents on T cell function
G Clutton, Y Xu, PL Baldoni, KR Mollan, J Kirchherr, W Newhard, K Cox, ...
Scientific reports 6 (1), 1-17, 2016
532016
ACTG 5202: final results of ABC/3TC or TDF/FTC with either EFV or ATV/r in treatment-naive HIV-infected patients
E Daar
17th Conference on Retroviruses & Opportunistic Infections (CROI 2010) San …, 2010
502010
Generalizing evidence from randomized trials using inverse probability of sampling weights
AL Buchanan, MG Hudgens, SR Cole, KR Mollan, PE Sax, ES Daar, ...
Journal of the Royal Statistical Society. Series A,(Statistics in Society …, 2018
482018
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention
MR Nicol, Y Fedoriw, M Mathews, HMA Prince, KB Patterson, E Geller, ...
The Journal of Clinical Pharmacology 54 (5), 574-583, 2014
462014
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and …
WC Miller, IF Hoffman, BS Hanscom, TV Ha, K Dumchev, Z Djoerban, ...
The Lancet 392 (10149), 747-759, 2018
362018
Ultra-long-acting removable drug delivery system for HIV treatment and prevention
M Kovarova, SR Benhabbour, I Massud, RA Spagnuolo, B Skinner, ...
Nature communications 9 (1), 1-11, 2018
322018
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection
CB Jabara, F Hu, KR Mollan, SE Williford, P Menezes, Y Yang, JJ Eron, ...
Antimicrobial agents and chemotherapy 58 (10), 6079-6092, 2014
322014
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
KY Smith, C Tierney, K Mollan, CS Venuto, C Budhathoki, Q Ma, ...
Clinical infectious diseases 58 (4), 555-563, 2014
302014
Disclosure of sexual orientation to health professionals in China: results from an online cross‐sectional study
W Tang, J Mao, S Tang, C Liu, K Mollan, B Cao, T Wong, Y Zhang, ...
Journal of the International AIDS Society 20 (1), 21416, 2017
282017
Impact of UGT1A1 Gilbert Variant on Discontinuation of Ritonavir-Boosted Atazanavir in AIDS Clinical Trials Group Study A5202
HJ Ribaudo, ES Daar, C Tierney, GD Morse, K Mollan, PE Sax, MA Fischl, ...
The Journal of infectious diseases 207 (3), 420-425, 2013
262013
Benefits and potential harms of HIV self-testing among men who have sex with men in China: an implementation perspective
Y Qin, W Tang, A Nowacki, K Mollan, SA Reifeis, MG Hudgens, NS Wong, ...
Sexually transmitted diseases 44 (4), 233, 2017
252017
Balancing trained immunity with persistent immune activation and the risk of simian immunodeficiency virus infection in infant macaques vaccinated with attenuated Mycobacterium …
K Jensen, MG dela Pena-Ponce, M Piatak, R Shoemaker, K Oswald, ...
Clinical and Vaccine Immunology 24 (1), 2017
242017
Race/ethnicity and the pharmacogenetics of reported suicidality with efavirenz among clinical trials participants
KR Mollan, C Tierney, JN Hellwege, JJ Eron, MG Hudgens, RM Gulick, ...
The Journal of infectious diseases 216 (5), 554-564, 2017
202017
The system can't perform the operation now. Try again later.
Articles 1–20